Abstract
The ability to rescue viable prostate precursor tissue from Rb−/− fetal mice has allowed for the generation of Rb−/− prostate tissue and Rb−/− prostate epithelial cell lines. Herein, we provide a protocol for the rescue of urogenital precursor tissue from mouse embryos harboring the lethal Rb−/− mutation. The rescued precursors can matured as subrenal capsule grafts in athymic mice. Subsequently prostatic tissue can be used as a source for Rb−/− epithelium in a tissue recombination protocol for the generation of chimeric prostate grafts in athymic male mouse hosts. We have also provided a detailed description for isolating and propagating the Rb−/− epithelium from such tissue recombinants as established cell lines. Methods for characterizing the grafts and cell lines by determining the retention of prostate-specific epithelial expression markers, including cytokeratins, the androgen receptor, estrogen receptor β and the dorsolateral prostatic secretory protein (mDLP) are given.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cunha, G. R., Hayward, S. W., Dahiya, R., and Foster, B. A. (1996) Smooth muscle-epithelial interactions in normal and neoplastic prostatic development. Acta Anatomica 155, 63–72.
Hayward, S. W., Cunha, G. R., and Dahiya, R. (1996) Normal development and carcinogenesis of the prostate: A unifying hypothesis. Ann. NY Acad. Sci. 784, 50–62.
Hayward, S. W., Rosen, M. A., and Cunha, G. R. (1997) Stromal-epithelial interactions in normal and neoplastic prostate. Br. J. Urol. 79(Suppl. 2), 18–26.
Cooke, D. B., Quarmby, V. E., Mickey, D. D., Isaacs, J. T., and French, F. S. (1988) Oncogene expression in prostate cancer: Dunning R3327 rat dorsal prostatic adenocarcinoma system. Prostate 13, 263–272.
Thompson, T. C., Kadmon, D., Timme, T. L., Merz, V. W., Egawa, S., Krebs, T., et al. (1991) Experimental oncogene induced prostate cancer, in Prostate Cancer: Cell and Molecular Mechanisms in Diagnosis and Treatment (Isaacs, J. T., ed.), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, pp. 55–72.
Peehl, D. M. (1993) Oncogenes in prostate cancer. Cancer 71, 1159–1164.
Wang, Y. Z. and Wong, Y. C. (1997) Oncogenes and tumor suppressor genes in prostate cancer: a review. Urol. Oncol. 3, 41–46.
Sarkar, F. H., Sakr, W., Li, Y. W., Macoska, J., Ball, D. E., and Crissman, J. D. (1992) Analysis of retinoblastoma (Rb) gene deletion in human prostatic carcinomas. Prostate 21, 145–152.
Isaacs, W. B., Bova, G. S., Morton, R. A., Bussemakers, M. J., Brooks, J. D., and Ewing, C. M. (1994) Genetic alterations in prostate cancer. Cold Spring Harb. Symp. Quant. Biol. 59, 653–659.
Fearon, E. R. and Vogelstein, B. (1990) A genetic model for colorectal tumorigenesis. Cell 61, 759–767.
Martin, K. J. and Sager, R. (1998) Expression genetics in cancer research, prognosis, and therapy. Adv. Exp. Med. Biol. 451, 1–7.
Bookstein, R., Rio, P., Madreperla, S. A., Hong, F., Allred, C., Grizzle, W. E., and Lee, W. H. (1990) Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma. Proc. Natl. Acad. Sci. USA 87, 7762–7766.
MacGrogan, D. and Bookstein, R. (1997) Tumour suppressor genes in prostate cancer. Semin. Cancer Biol. 8, 11–19.
Yeh, S., Miyamoto, H., Nishimura, K., Kang, H., Ludlow, J., Hsiao, P., et al. (1998) Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells. Biochem. Biophys. Res. Commun. 248, 361–367.
Weinberg, R. A. (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323–330.
Dyson, N. (1998) The regulation of E2F by pRb-family proteins. Genes Dev. 12, 2245–2262.
Dalbagni, G., Cordon-Cardo, C., Reuter, V., and Fair, W. R. (1995) Tumor suppressor gene alterations in bladder carcinoma. Translational correlates to clinical practice. Surg. Oncol. Clin. N Am. 4, 231–240.
Trudel, M., Mulligan, L., Cavenee, W., Margolese, R., Cote, J., and Gariepy, G. (1992) Retinoblastoma and p53 gene product expression in breast carcinoma: immunohistochemical analysis and clinicopathologic correlation. Hum. Pathol. 23, 1388–1394.
Tamura, G., Maesawa, C., Suzuki, Y., Kashiwaba, M., Ishida, M., Saito, K., and Satodate, R. (1994) Improved detection of loss of heterozygosity at retinoblastoma gene locus in human breast carcinoma. Pathol. Int. 44, 34–38.
Berns, E. M., de Klein, A., van Putten, W. L., van Staveren, I. L., Bootsma, A., Klijn, J. G., and Foekens, J. A. (1995) Association between RB-1 gene alterations and factors of favourable prognosis in human breast cancer, without effect on survival. Int. J. Cancer 64, 140–145.
Mori, N., Yokota, J., Akiyama, T., Sameshima, Y., Okamoto, A., Mizoguchi, H., et al. (1990) Variable mutations of the RB gene in small-cell lung carcinoma. Oncogene 5, 1713–1717.
Reissmann, P. T., Koga, H., Takahashi, R., Figlin, R. A., Holmes, E. C., Piantadosi, S., et al. (1993) Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group. Oncogene 8, 1913–1919.
Linardopoulos, S., Gonos, E. S., and Spandidos, D. A. (1993) Abnormalities of retinoblastoma gene structure in human lung tumors. Cancer Lett. 71, 67–74.
Phillips, S. M., Morton, D. G., Lee, S. J., Wallace, D. M., and Neoptolemos, J. P. (1994) Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancer. Br. J. Urol. 73, 390–395.
Phillips, S. M., Barton, C. M., Lee, S. J., Morton, D. G., Wallace, D. M., Lemoine, N. R., and Neoptolemos, J. P. (1994) Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis. Br. J. Cancer 70, 1252–1257.
Melamed, J., Einhorn, J. M., and Ittmann, M. M. (1997) Allelic loss on chromosome 13q in human prostate carcinoma. Clin. Cancer Res. 3, 1867–1872.
Kubota, Y., Fujinami, K., Uemura, H., Dobashi, Y., Miyamoto, H., Iwasaki, Y., et al. (1995) Retinoblastoma gene mutations in primary human prostate cancer. Prostate 27, 314–320.
Ittmann, M. M. and Wieczorek, R. (1996) Alterations of the retinoblastoma gene in clinically localized, stage B prostate adenocarcinomas. Hum. Pathol. 27, 28–34.
Brooks, J. D., Bova, G. S., and Isaacs, W. B. (1995) Allelic loss of the retinoblastoma gene in primary human prostatic adenocarcinomas. Prostate 26, 35–39.
Bookstein, R. (1994) Tumor suppressor genes in prostatic oncogenesis. J. Cell. Biochem. 19(Suppl.), 217–223.
Vesalainen, S. and Lipponen, P. (1995) Expression of retinoblastoma gene (Rb) protein in T12M0 prostatic adenocarcinoma. J. Cancer Res. Clin. Oncol. 121, 429–433.
Geradts, J., Hu, S., Lincoln, C., Benedict, W., and Xu, H. (1994) Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer 58, 161–167.
Wang, Y., Hayward, S., Donjacour, A., Young, P., Jacks, T., Sage, J., et al. (2000) Sex hormone-induced carcinogenesis in Rb-deficient prostate tissue. Cancer Res. 60, 6008–6017.
Cunha, G. R. and Donjacour, A. A. (1987) Mesenchymal-epithelial interactions: Technical considerations, in Assessment of Current Concepts and Approaches to the Study of Prostate Cancer (Coffey, D. S., Bruchovsky, N., Gardner, W. A., Resnick, M. I., and Karr, J. P., eds.), A.R. Liss, New York, pp. 273–282.
Donjacour, A. A., Rosales, A., Higgins, S. J., and Cunha, G. R. (1990) Characterization of antibodies to androgen-dependent secretory proteins of the mouse dorsolateral prostate. Endocrinology 126, 1343–1354.
Cunha, G. R., Lung, B., and Kato, K. (1977) Role of the epithelial-stromal interaction during the development and expression of ovary-independent vaginal hyperplasia. Dev. Biol. 56, 52–67.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Hayward, S.W., Wang, Y., Day, M.L. (2003). Rescue and Isolation of Rb-deficient Prostate Epithelium by Tissue Recombination. In: Terrian, D.M. (eds) Cancer Cell Signaling. Methods in Molecular Biology™, vol 218. Humana Press. https://doi.org/10.1385/1-59259-356-9:17
Download citation
DOI: https://doi.org/10.1385/1-59259-356-9:17
Publisher Name: Humana Press
Print ISBN: 978-1-58829-075-5
Online ISBN: 978-1-59259-356-9
eBook Packages: Springer Protocols